0001610717-23-000222.txt : 20230803
0001610717-23-000222.hdr.sgml : 20230803
20230803162342
ACCESSION NUMBER: 0001610717-23-000222
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230801
FILED AS OF DATE: 20230803
DATE AS OF CHANGE: 20230803
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hindson Benjamin J.
CENTRAL INDEX KEY: 0001786391
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39035
FILM NUMBER: 231140443
MAIL ADDRESS:
STREET 1: 10X GENOMICS, INC.
STREET 2: 6230 STONERIDGE MALL ROAD
CITY: PLEASANTON
STATE: CA
ZIP: 94588
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 10x Genomics, Inc.
CENTRAL INDEX KEY: 0001770787
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 455614458
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6230 STONERIDGE MALL ROAD
CITY: PLEASANTON
STATE: CA
ZIP: 94588
BUSINESS PHONE: (925) 401-7300
MAIL ADDRESS:
STREET 1: 6230 STONERIDGE MALL ROAD
CITY: PLEASANTON
STATE: CA
ZIP: 94588
FORMER COMPANY:
FORMER CONFORMED NAME: 10X Genomics, Inc.
DATE OF NAME CHANGE: 20190315
4
1
form4.xml
X0508
4
2023-08-01
0001770787
10x Genomics, Inc.
TXG
0001786391
Hindson Benjamin J.
10X GENOMICS, INC.
6230 STONERIDGE MALL ROAD
PLEASANTON
CA
94588
true
true
See Remarks
true
Class A Common Stock
2023-08-01
4
M
0
6970
11.48
A
291206
D
Class A Common Stock
2023-08-01
4
S
0
1727
61.7714
D
289479
D
Class A Common Stock
2023-08-01
4
S
0
5243
62.3561
D
284236
D
Stock Option (right to buy)
11.48
2023-08-01
4
M
0
6970
0
D
2029-05-10
Class A Common Stock
6970
23312
D
The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 13, 2023.
This transaction was executed in multiple trades at prices ranging from $61.12 to $62.11. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
This transaction was executed in multiple trades at prices ranging from $62.12 to $62.70. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
All of the shares subject to the option are fully vested and exercisable as of the date hereof.
President and Chief Scientific Officer
/s/ Eric S. Whitaker, as Attorney-in-Fact for Benjamin J. Hindson
2023-08-03